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Abstract 
Police services in a number of Australian states and overseas jurisdictions have begun to 
implement or consider random road-side drug testing of drivers. This paper outlines 
research conducted to provide an estimate of the extent of drug driving in a sample of 
Queensland drivers in regional, rural and metropolitan areas. Oral fluid samples were 
collected from 2657 Queensland motorists and screened for illicit substances including 
cannabis (delta 9 tetrahydrocannibinol [THC]), amphetamines, ecstasy, and cocaine. 
Overall, 3.8% of the sample (n = 101) screened positive for at least one illicit substance, 
although multiple drugs were identified in a sample of 23 respondents. The most common 
drugs detected in oral fluid were ecstasy (n = 53), and cannabis (n = 46) followed by 
amphetamines (n = 23). A key finding was that cannabis was confirmed as the most 
common self-reported drug combined with driving and that individuals who tested positive 
to any drug through oral fluid analysis were also more likely to report the highest frequency 
of drug driving. Furthermore, a comparison between drug vs. drink driving detection rates 
for one region of the study, revealed a higher detection rate for drug driving (3.8%) vs. 
drink driving (0.8%). This research provides evidence that drug driving is relatively 
prevalent on Queensland roads, and may in fact be more common than drink driving. This 
paper will further outline the study findings’ and present possible directions for future drug 
driving research. 
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1. Introduction 
Presently, there is an increasingly amount of research effort focused on 
determining the prevalence and impact of drug driving on public roads. Firstly, 
research has found a strong association between drug driving and culpability, with 
accident risk estimated as high as a driver with a blood alcohol content of 0.1 to 0.15 
percent (Drummer, Gerostamoulos, Batziris, Chu, Capelhorn, Robertson & Swann, 
2003). Secondly, a considerable body of literature is accumulating that has focused on 
detecting the presence of drugs in body fluids of those who have been involved in a 
crash (Del Rio, Gomez, Sancho & Alvarez, 2002; Drummer et al., 2003).  For 
example, it has been shown that drug use has been detected in anywhere between 8.8% 
and 39.6% of fatally injured drivers (Del Rio et al., 2002; Drummer et al., 2003; 
Gjerde, Beylich & Morland, 1993; Mura, Chatelain, Dumestre, Gaulier, Ghysel,  
Lacroix  et al., 2006; Seymour & Oliver, 1999; Swann, Boorman & Papafotiou, 2004). 
In general, the predominant illicit drug found in the systems of the majority of such 
drivers is cannabis, with this substance also prevalent among crash-involved, but non-
fatally injured drug drivers. Additionally, use of illicit substances, including the 
predominant cannabis substance, among this group is also elevated and has been 
reported to be between 2.7% and 41.3% for such drivers (Athanaselis, Dona, 
Papadodima, Papoutsis, Maravelias & Koutselinis, 1999; Longo, Hunter, Lokan, 
White & White, 2000; Soderstrom, Dischinger, Kerns & Trifillis, 1995; Stoduto, 
Vingilis, Kapur, Sheu, McLellan & Liban, 1993; Waller, Blow, Maio, Singer, Hill & 
Schaefer, 1997).   
 
However, currently questions remain regarding the prevalence of individuals who 
engage in drug driving practices that have yet to be apprehended or involved in a 
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crash. The main avenue for obtaining such information has been through self-report 
data provided by motorists, which has indicated that the self-reported prevalence of 
drug driving varies markedly between 2% and 90% of respondents, although the 
largest body of research suggests between 3% and 10% (Kelly, Darke & Ross, 2004).  
Historically, the prevailing view of drug driving in the community is that it is 
relatively uncommon amongst the general driving population (Kelly et al, 2004).  
However, research has shown that among some subcultures, the percentage of drug 
driving may be much higher. For instance, amphetamine use among a sample of 
nightclub attendees has been found to be 62% (Akram, 1997), while drug driving 
among a sample of cannabis users has been reported to be approximately 82% (Terry 
& Wright, 2005). Nevertheless, research has generally indicated that the most common 
drugs combined with driving is cannabis (Davey, Leal & Freeman, 2007; Drummer et 
al., 2003; Terry & Wright, 2005), which may in part be associated with perceptions 
that cannabis does not have a negative impact on driving performance (Terry & 
Wright, 2005).   
 
In contrast, research studies that have included the collection of bodily fluids have 
predominantly involved drivers who are already suspected of driving under the 
influence of alcohol and/or drugs. Currently, a number of drug testing trials are 
underway in different countries, however presently only preliminary published 
research exists regarding the output of these studies or the strengths and limitations of 
the research method. An early oral fluid study conducted in the United Kingdom 
reported 4.7% of drivers from a random sample of non-crash drivers were confirmed 
positive to the presence of drugs (Buttress, Tunbridge, Oliver, Torrance, & Wylie, 
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2004), while a German study identified illicit substances in 16.8% of a sample of 
motorists (Wylie, Torrance, Seymour, Buttress & Oliver, 2005). 
One of the first Australian studies, implemented by the Victorian police force, 
reported a drug driving prevalence rate of one driver in 40 (2.4%) for cannabis and 
amphetamines, which is more than double the positive alcohol-driving rate (Drummer, 
Gerostamoulos, Chu, Swann, Boorman, & Cairns, 2007). An even larger detection rate 
was reported in a three-year study of police traffic detainees in three Australian states, 
as the researchers reported that 70% tested positive to one drug and approximately one 
third (e.g., 38%) tested positive to more than one drug (Poyser, Makkai, Norman, & 
Mills, 2002).  Smaller Australian studies that have focused on young drivers (e.g., 
university students) have also revealed similar results, with between 8.2% and 15% of 
motorists reported driving after consuming some form of illicit substance on a yearly 
basis (Armstrong, Wills and Watson 2005; Davey, Davey and Obst 2005). These 
preliminary findings indicate that drug driving presents as a serious threat to road 
safety, and additionally prompts the need for further research to determining the 
prevalence of non-crash drug driving rates in Australia. 
 
As a result, the major objectives of this study were to: 
• Measure the prevalence of drug driving among a sample of Queensland 
drivers in three areas of Queensland; and 
• Investigate the self-reported frequency of general motorists’ involvement in 
drug driving behaviour. 
 
2. Method  
2.1. Participants, Materials and Procedure 
 6
Drivers stopped at Random Breath Testing (RBT) operations across 3 locations in 
Queensland in 2006-2007 (e.g., Brisbane, Townsville1 & Gold Coast) were 
approached and asked by operational police to participate in the drug driving research, 
which was positioned on average 50 metres further down the road. Participation was 
voluntary and involved completing a self-report questionnaire regarding recent illicit 
drug use and drug driving in the previous 12 months, and providing a sample of oral 
fluid that could later be screened for the presence of drugs. The procedure took 
approximately 10-20 minutes to complete and drivers received a one-off payment of 
$20 cash to reimburse them for their time. Variations in time to collect the sample 
were dependent upon the amount of saliva in participants’ mouths, although such 
issues did not affect participation in the study nor analysis of the sample.  Data was 
usually collected between the hours of 5pm and 1am2.   
 
A 12 item self-report questionnaire was designed to assess a variety of 
demographic data (e.g., gender, age, years driving) as well as self-reported drug use 
and the frequency of drug driving behaviour. Participants responded to questions that 
investigated the most recent use of marijuana / cannabis (within four hours, within the 
last 24 hours, within the last week, within the last month, within the last year, more 
than a year ago, have never used). This question was repeated for meth / 
amphetamines (such as speed, oil, base, crystal, ecstasy), heroin and cocaine. 
Participants were also required to indicate how often in the previous 12 months they 
had operated a motor vehicle (including a motorcycle) within four hours of using 
                                                 
1 It is noted that the data collected exclusively from the Townsville area has previously been published 
(Davey et al., 2007). 
2 Workplace health and safety requirements resulted in the current roadside project only being 
implemented with the presence of the Queensland Police Service.  RBT operations were deemed to be 
the most compatible roadside activity and thus drug testing procedures corresponded within traditional 
RBT operational hours e.g., 5pm – 1am.   
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marijuana / cannabis (every day, more than once a week, about once a week, 11 – 20 
times, 3 – 10 times, once or twice, never). Once again, this question was repeated for 
meth / amphetamines (such as speed, oil, base, crystal, ecstasy), heroin and cocaine. 
The majority of data was descriptive and/or categorical, and recorded as percentage 
frequencies, and thus, chi-square tests were performed where appropriate.   
 
In addition, oral fluid samples were collected, stored and screened off-site at a later 
date using the Cozart® RapiScan oral fluid drug test device. Participants provided a 
sample of oral fluid that was collected from inside their mouth via a pad held either 
under their tongue or beside the inside of their cheek. The five-panel cannabis and 
single-panel methamphetamine / MDMA test cartridges were used (i.e. each sample 
was screened twice). Each Cozart® RapiScan kit consisted of a collector, transport 
tube containing buffer solution, separator filter tube, pipette and test cartridge. The 
five-panel cannabis cartridge detected the presence of benzodiazepines, amphetamines, 
cannabis (THC), and cocaine, while the single-panel methamphetamine / MDMA 
cartridge detected the presence of methamphetamine and MDMA. There was no 
subjectivity in the interpretation of results as the Cozart® RapiScan testing instrument 
displayed and printed results. 
 
3. Results 
3.1 Sample and Response Rate 
A total of 2657 motorists participated in the studies which were conducted over 
three regions: (i) Brisbane n = 1587, (ii) Townsville n = 794 & (iii) Gold Coast n = 
276.  Due to resourcing constraints and the referral process from the Police RBT site, 
it was not possible to obtain an accurate measurement of the response rate over the 
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entire data collection period3. However, on one occasion the response rate was 
assessed across two sites during a shift where an additional researcher counted the 
number of drivers approached to participate and noted their response. Drivers of 63 
cars from a total of 85 participated in the project, resulting in a response rate of 
74.12%.  
 
Overall, more than half the participants were male (n = 1670, 63.5%), and were 
aged between 16 and 66 years (mean age = 28.74 years, SD = 11.57). On average, 
participants had been driving for 11.04 years (SD = 11.57). Most reported driving 
daily (n = 2181, 82.9%) or three to five times per week (n = 385, 14.5%).  
 
3.2 Prevalence of Positive Drug Tests 
Screening analysis revealed that oral fluid samples from 101 drivers (3.8% of the 
total sample) contained at least one illicit substance. A comparison was undertaken 
between the drink driving and drug driving detection rates for the Townsville area 
which revealed that drug driving detection rates was more prevalent (4.91%) than 
drink driving (0.8%4). Table 1 outlines the results by drug group detected in the three 
regions. As depicted in Table 1, the most common drug detected was the ecstasy 
(MDMA) group (53 cases), followed by cannabis (THC) (46 cases), amphetamines (23 
cases) and cocaine (4 cases). There were relatively minimal proportional differences 
identified in drug frequency between the regions, although it is noted that detection 
rates for MDMA were highest in Brisbane, while delta 9 THC was most commonly 
detected in Townsville. In regards to combined substances, 21 samples were screened 
                                                 
3 The procedure usually consisted of RBT operational police officers informing motorists (who had 
given a breath sample) that they had the opportunity to participate in an anonymous research drug 
driving project being conducted approximately 50 metres down the road.   
4 Relatively few individuals charged with drink driving participated in the drug driving research, and 
thus the drug and drinking drivers consisted of separate samples.   
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as positive for 2 drugs, while 2 samples tested positive for 3 drugs. Not surprisingly 
(due to illicit manufacturing recipes), the most common combination of drugs were 
amphetamines and MDMA (65%).  
 
Compared with the total participant pool, the 101 drivers who provided samples 
that were confirmed positive for at least one illicit substance were more likely to be 
male (n = 82, 81.1%), marginally younger than non-positive participants (M = 25 
years, SD = 7.7 versus M = 28, SD = 11.65) had less driving experience (M = 7.8 
years, SD = 7.7 versus M = 9.9, SD = 11.1), but they did not report a higher frequency 
of general driving. Further, males were 4 times more likely engage in poly drug use (n 
= 20, 87%). 
 
INSERT TABLE 1 HERE 
 
3.3 Self-reported Prevalence of Drug Driving 
In addition to the analysis of body fluids, an investigation was also undertaken to 
examine participants’ self-reported drug use and drug driving behaviours. Firstly, regarding 
drug use, the most commonly consumed drug was cannabis, with 23.6% (n = 627) reporting 
the use of the substance within the last year, and 8.3% (n = 220) of this group reporting 
usage in the last week. In contrast, only 8.9% (n = 236) reported amphetamine use in the 
last year and 8.3% ( n = 220) MDMA use in the last year. A point to note is that in 
Queensland many illicit drug users refer to methylamphetamine as amphetamine. Finally, 
3.1% (n = 82) reported using cocaine and 0.3% (n = 8) of the sample reported using heroin 
during the last year. Chi-square analysis revealed males were more likely to report regular 
cannabis use than females X2 (6, N = 2657, = 43.41, p <.001), while small cell sizes 
precluded analysis of the other substances. Differences were identified between the regions 
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on self-reported frequency of drug use, as participants in Townsville reported proportionally 
higher frequencies of cannabis use, X2 (12, N = 2657, = 25.531, p =.012), while the Gold 
Coast reported highest amphetamine consumption (n = 443, 16.7% within the last year) and 
MDMA usage (n = 499, 18.8% within the last year). However, small cell sizes excluded 
further chi-square analysis of the regions. 
 
For drug driving, similar to the above findings, the most common substance combined 
with driving was reported to be cannabis (see Table 2). Specifically, 4.4% of the sample 
reported using cannabis before driving at least once a week, while approximately 1.0% 
reported the use of amphetamines, and less than 1.0% reporting cocaine or heroin use while 
driving in a week. There were no meaningful significant differences identified between the 
regions on self-reported frequency of drug driving. Finally, examination of the self-reported 
drug use for the 101 individuals who tested positive to the presence of drugs revealed that 
drug driving was most common among these individuals. For example, 68 (67.3%) reported 
driving within four hours of using at least one of the drugs outlined on the questionnaire. 
This proportion is more than four times the proportion of the total sample of 2657 drivers 
that reported drug driving (412 drivers, 15.5%). Furthermore, 32 (55.2%) of the drivers who 
provided samples that were confirmed positive for at least one illicit substance reported 
drug driving frequently (that is, once a week or more). This is more than 10 times the 
proportion of the total sample that reported frequently drug driving (61 drivers, 3.8%).  
 
 
INSERT TABLE 2 HERE 
 
4. Discussion 
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This paper aimed to report on an investigation into the prevalence of drug driving 
in three Queensland regions through both self-reported data and random roadside drug 
testing technology. Specifically, the study focused on measuring the self-reported 
prevalence of drug driving in three areas, as well as the major drug types that may be 
used when driving.  
 
4.1 Prevalence of Positive Drug Tests 
The first major finding of the study was that the examination of oral fluid samples 
revealed that 3.8% (n =101) of the sample provided a positive illicit drug reading. The 
finding is consistent with the small amount of preliminary Australian research that has 
focused on randomly drug testing motorists through oral fluid analysis (Drummer et 
al., 2007).  In addition, the detection rate for drug drivers (in the current case) appears 
higher than the corresponding detection rates for drink drivers in Queensland (Davey 
et al., 2007; Freeman & Watson, 2006). However, it is noted that these findings are 
only preliminary and the data sample for the current study focused only on three 
locations for a relatively brief period of time.  Secondly, and as previously reported 
(Davey et al., 2007) a comparison with the corresponding drink driving detection rates 
for the Townsville RBT sites revealed a greater percentage of identified drug drivers 
than drink drivers. Whilst only preliminary, the results suggest that a greater 
proportion of drivers may be at risk of driving under the influence of drugs, rather than 
alcohol, in the early hours of the morning.   
 
Not surprisingly, individuals who tested positive to drugs were more likely to be 
young drivers, with lower levels of driving experience. Importantly, while males were 
more likely to test positive for illicit substances, a sizeable proportion of females also 
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tested positive, which indicates this group is also at risk of driving after consuming 
drugs. The results are somewhat consistent with general drug research that has 
consistently indicated that males are more likely to consume illicit substances than 
females (Davey et al., 2007).  However, it is noteworthy that males were more likely 
to test positive to poly drug use (n = 20, 87%).   
 
Interestingly, a proportion of the sample that were screened positive contained 
more than one amphetamine type substance. One possible explanation for the 
detection of multiple illicit drugs is the manufacturing process, as recreational “party” 
drugs (e.g., ecstasy) are likely to contain more than one substance. Examination of the 
self-reported data revealed that cannabis was the most frequently consumed illicit 
substance, and not surprisingly, was also the most frequent self-reported drug to be 
used when driving. This finding is again consistent with self-report research that 
indicates cannabis is the most commonly combined drug with driving (Davey et al., 
2007; Drummer et al., 2003; Terry & Wright, 2005), although it is noted that drug 
detection rates may prove to vary with specific locations. However, a greater number 
of amphetamines were detected through the screening process in the current study.  
Further research is required to determine whether this finding is a data anomaly, 
screening issue or if amphetamines, are in fact, more likely to be combined with 
driving in the late evening and early hours of the morning. A more consistent finding 
was that individuals who tested positive to the drug testing process also reported the 
highest rate of drug driving, which provides support for the drug screening process. 
Finally, there were few differences identified between the regions on key measures 
such as the number of positive samples or self-reported drug driving behaviours. The 
 13
results indicate that drug driving may prove to be a state-wide problem and that drug 
testing may have the capacity to detect a considerable proportion of drug drivers.    
 
4.2 Limitations  
When interpreting the findings, a number of methodological limitations related to 
the study should be kept in mind. The generalisability of the results in this study may 
be limited, as the data was sampled from specific areas of Queensland, and it is 
therefore expected that the prevalence of drug use (and therefore, drug driving) may 
fluctuate by area due to issues relating to the supply, demand and cost of drugs. In 
addition, the sample was skewed towards the younger age groups (M = 28 years) even 
though a large age range was detected. Conversely, the sample may be representative 
of a peak drug driving period, at night on weekends when this sample was taken. 
However, it is possible that drug driving rates may increase or decrease further into the 
early hours of the morning as well as during the day, given that data for this sample 
was only collected between the hours of 5pm and 1 am.  Further, the prospect of self-
report and volunteer bias persists, and even though the Queensland Police Service 
were not specifically involved in the study, it is possible that operational officers’ 
presence at the research site deterred some individuals from participating (especially 
those under the influence of drugs). Uncertainties also remain about the reliability of 
saliva testing for illicit drugs, as environmental contaminations may negatively impact 
on the accuracy of saliva testing, such as a person’s presence in an area where 
cannabis is being smoked (e.g., Davey et al., 2007).  Furthermore, this testing 
approach requires samples to be stored at specific temperatures, and any variations 
may negatively impact upon the accuracy of the results.   Additionally, this study does 
not include confirmatory analysis, which would have further improved the accuracy of 
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the results.  Taking this into consideration, it would be ideal to replicate and/or expand 
the present study with a wider sample from urban, regional and rural areas across 
Queensland. 
 
Overall, this study has provided evidence that driving under the influence of 
drugs may be comparatively prevalent in some areas of Queensland and therefore drug 
driving may present as a critical issue in road safety. In attempt to reduce drug driving, 
the recent induction of random roadside drug testing legislation in Queensland appears 
to be an important development. Previous research has suggested that perceptions of 
apprehension uncertainty are an important factor in deterring both drug drivers 
(Davey, Davies, French, Williams, & Lang, 2005) and drink drivers (Piquero & 
Pogarsky, 2002) from engaging in criminal behaviours. As a result, the 
implementation of the new detection method has the potential to influence the 
prevalence of drug driving. In addition, further research may benefit from examining 
motorists’ current perceptions concerning the probability of being detected for drug 
driving, and their corresponding beliefs about the effectiveness and impact of saliva 
testing on the prevalence of offending. Such information would offer further 
information concerning the most effective system to implement and reinforce the 
deterrent factor of random roadside drug testing. Conversely, further investigation into 
the prevalence, effect and prevention of drug driving can only help with the 
development and implementation of effective countermeasures targeted at decreasing 
the burden of drug driving on road safety. 
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Tables 
Table 1. Number and Proportion of Positive Screening Tests by Drug Group  
  Total
3 
 N = 2657 
 Brisbane 
 N = 1587 
 Townsville 
 N = 794 
 Gold Coast 
 N = 276 
Ecstasy (MDMA)  53 (1.99%) 35 (2.21%) 16 (2.02%)  2 (0.72%) 
Cannabis (THC)  46 (1.73%) 20 (1.26%) 20 (2.52%)  6 (2.17%) 
Amphetamines  23 (0.86%) 17 (1.07%) 3 (0.38%)  3 (1.08%) 
 Cocaine  6 (0.22%) 2 (0.13%) 2 (0.25%)  2 (0.72%) 
Total Illicit Substances4  128 (4.82%) 74 (4.66%) 41 (5.16%)  13 (4.71%) 
 
___________________________________________________________________ 
3 29 respondents did not provide their gender. 
4 23 respondents screened positive to more than one drug 
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Table 2. Self-reported Drug Driving Behaviour within Four Hours of Consumption  
 
Drug Type  Cannabis Amphetamines  Ecstasy  Cocaine  Heroin 
 n  %  n  %  n  %  n  %  n  % 
Gold Coast 
 Every day 
 More than once week 
 About once a week 
 11 - 20 times 
 3 - 10 times 
 Once or twice 
 Never 
 
 6
 4
 3
 3
 5
 15
238
 
(2.2) 
(1.4) 
(1.1) 
(1.1) 
(1.8) 
(5.4) 
(86.2) 
 
 
 0 
 4 
 0 
 5 
 3 
 10 
 253 
 
(0.0) 
(1.4) 
(0.0) 
(1.8) 
(1.1) 
(3.6) 
(91.7) 
 
 1 
 1 
 4 
 4 
 3 
 16 
 246 
 
(0.4)
(0.4)
(1.4)
(1.4)
(1.1)
(5.8)
(89.1)
 
 0 
 0 
 2 
 2 
 2 
 12 
 257 
 
(0.0) 
(0.0) 
(0.7) 
(0.7) 
(0.7) 
(4.3) 
(93.1) 
 
 1 
 0 
 0 
 0 
 0 
 1 
 273 
 
 
 
 0 
 1 
 0 
 0 
 4 
 5 
 1568 
 
 
 
 1 
 0 
 0 
 0 
 0 
 2
 755 
 
(0.4) 
(0.0) 
(0.0) 
(0.0) 
(0.0) 
(0.4) 
(98.9) 
 
 
 
(0.0) 
(0.1) 
(0.0) 
(0.0) 
(0.3) 
(0.3) 
(98.8) 
 
 
 
(0.1) 
(0.0) 
(0.0) 
(0.0) 
(0.0) 
(0.3) 
(99.6) 
 
Brisbane 
 Every day 
 More than once week 
 About once a week 
 11 - 20 times 
 3 - 10 times 
 Once or twice 
 Never 
 
 
 26
 20
 19
 14
 18
 76
 1399
 
(1.6) 
(1.3) 
(1.2) 
(0.9) 
(1.1) 
(4.8) 
(88.2) 
 
 
 3 
 3 
 12 
 12 
 12 
 28 
1509 
 
(0.2) 
(0.2) 
(0.8) 
(0.8) 
(0.8) 
(1.8) 
(95.1) 
 
 1 
 6 
 4 
 7 
 20 
 58 
1481 
 
(0.1)
(0.4)
(0.3)
(0.4)
(1.3)
(3.7)
(93.3)
 
 0 
 0 
 0 
 6 
 5 
 22 
 1545 
 
(0.0) 
(0.0) 
(0.0) 
(0.4) 
(0.3) 
(1.4) 
(97.4) 
Townsville 
 Every day 
 More than once week 
 About once a week 
 11 - 20 times 
 3 - 10 times 
 Once or twice 
 Never 
 
 
 14
 13
 10
 9
 15
 63
 632
 
(1.8) 
(1.6) 
(1.3) 
(1.1) 
(1.9) 
(8.3) 
(84.0) 
 
 1 
 2 
 3 
 8 
 5 
 17 
 722 
 
(0.1) 
(0.3) 
(0.4) 
(1.0) 
(0.6) 
(2.1) 
(95.5) 
 
 - 
 - 
 - 
 - 
 - 
 - 
 -
 
 - 
 - 
 - 
 - 
 - 
 - 
 - 
 
 1 
 2 
 0 
 0 
 0 
 0 
 755 
 
(0.1) 
(0.3) 
(0.0) 
(0.0) 
(0.0) 
(0.0) 
(99.6) 
• Note: The questionnaire for reporting drug driving behaviour was modified to include ecstasy 
after testing had been completed in Townsville.  
